Stephen A. Tullman is Director at Aclaris Therapeutics, Inc. (ACRS). They have made 4 open-market trades across 1 company since 2018, most recently 2018-10-04.
CIK 0001654343
4 open-market purchases totalling $840K since 2018, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ACRS | 177,457 | $582K |
Shares reported on the most recent Form 4, priced at the 2018-10-05 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.